Utilisation of Pharmacokinetic- Pharmacodynamic Modelling and Simulation in Regulatory Decision-Making

ISSN： 0312-5963

Source： Clinical Pharmacokinetics, Vol.40, Iss.12, 2001-01, pp. : 883-892

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Current and future directions of pharmacokinetic and pharmacokinetic–pharmacodynamic modelling and simulation: Population Approach Group in Europe 19th annual meeting

By Kloft Charlotte Poggesi Italo

Expert Opinion on Drug Metabolism and Toxicology, Vol. 6, Iss. 12, 2010-12 ,pp. : 1599-1604

Informa Healthcare

Access to resources Recommend Favorite

Biomarkers, Validation and Pharmacokinetic-Pharmacodynamic Modelling

By Colburn W.A.

Clinical Pharmacokinetics, Vol. 42, Iss. 12, 2003-01 ,pp. : 997-1022

Adis International

Access to resources Recommend Favorite

Pharmacokinetic/Pharmacodynamic Modelling in Diabetes Mellitus

By Landersdorfer Cornelia B. Jusko William J.

Clinical Pharmacokinetics, Vol. 47, Iss. 7, 2008-01 ,pp. : 417-448

Adis International

Access to resources Recommend Favorite

Methodological Issues in Pharmacokinetic-Pharmacodynamic Modelling

By Bellissant E.

Clinical Pharmacokinetics, Vol. 35, Iss. 2, 1998-08 ,pp. : 151-166

Adis International

Access to resources Recommend Favorite

Gene Therapy: A Pharmacokinetic/Pharmacodynamic Modelling Overview

By Parra-Guillén Zinnia González-Aseguinolaza Gloria Berraondo Pedro Trocóniz Iñaki

Pharmaceutical Research, Vol. 27, Iss. 8, 2010-08 ,pp. : 1487-1497

Springer Publishing Company

Access to resources Recommend Favorite